Journal of Tuberculosis and Lung Health ›› 2018, Vol. 7 ›› Issue (4): 323-327.doi: 10.3969/j.issn.2095-3755.2018.04.019
• Review Articles • Previous Articles Next Articles
Chao-gang XIONG(),Fei REN,Xiao-hui LYU,Lei-peng REN,Jun ZHOU,Ying LI
Received:
2018-10-24
Online:
2018-12-30
Published:
2019-01-08
Contact:
Chao-gang XIONG
E-mail:499478967@qq.com
Chao-gang XIONG,Fei REN,Xiao-hui LYU,Lei-peng REN,Jun ZHOU,Ying LI. Research progress of desensitization therapy and cutaneous adverse drug reactions induced by rifampicin and isoniazid[J]. Journal of Tuberculosis and Lung Health , 2018, 7(4): 323-327. doi: 10.3969/j.issn.2095-3755.2018.04.019
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.jtbld.cn/EN/10.3969/j.issn.2095-3755.2018.04.019
时间(d) | 时间点 | 利福平(mg) | 配置液 |
---|---|---|---|
1 | 9:00am | 0.0003(1ml配置液) | 300mg溶解于1000000ml水中 |
6:00pm | 0.0009(3ml配置液) | 300mg溶解于1000000ml水中 | |
2 | 9:00am | 0.003(1ml配置液) | 300mg溶解于100000ml水中 |
6:00pm | 0.009(3ml配置液) | 300mg溶解于100000ml水中 | |
3 | 9:00am | 0.03(1ml配置液) | 300mg溶解于10000ml水中 |
6:00pm | 0.09(3ml配置液) | 300mg溶解于10000ml水中 | |
4 | 9:00am | 0.3(1ml配置液) | 300mg溶解于1000ml水中 |
6:00pm | 0.9(3ml配置液) | 300mg溶解于1000ml水中 | |
5 | 9:00am | 3(1ml配置液) | 300mg溶解于100ml水中 |
6:00pm | 6(3ml配置液) | 300mg溶解于100ml水中 | |
6 | 9:00am | 12(4ml配置液) | 300mg溶解于100ml水中 |
6:00pm | 24(8ml配置液) | 300mg溶解于100ml水中 | |
7 | 9:00am | 30(1ml配置液) | 300mg溶解于10ml水中 |
6:00pm | 60(2ml配置液) | 300mg溶解于10ml水中 | |
8 | 9:00am | 90(3ml配置液) | 300mg溶解于10ml水中 |
6:00pm | 120(4ml配置液) | 300mg溶解于10ml水中 | |
9 | 9:00am | 150(5ml配置液) | 300mg溶解于10ml水中 |
6:00pm | 180(6ml配置液) | 300mg溶解于10ml水中 | |
10 | 9:00am | 210(7ml配置液) | 300mg溶解于10ml水中 |
6:00pm | 240(8ml配置液) | 300mg溶解于10ml水中 | |
11 | 9:00am | 240(8ml配置液) | 300mg溶解于10ml水中 |
6:00pm | 240(8ml配置液) | 300mg溶解于10ml水中 | |
12~13 | 9:00am | 300 | 300mg/片 |
14 | 9:00am | 450 | 450mg/片 |
[1] | 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508. |
[2] |
吴小梅, 蔡颖, 刘巍 . 抗结核药物致超敏反应综合征.17例. 四川医学, 2015,36(11):1581-1583.
doi: 10.16252/j.cnki.issn1004-0501-2015.11.029 URL |
[3] |
Siripassorn K, Ruxrungtham K, Manosuthi W . Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs. Int J Infect Dis, 2018,68:61-68.
doi: 10.1016/j.ijid.2018.01.006 URL pmid: 29410254 |
[4] |
Tsuyuguchi K, Wada M . Management of adverse effects with antituberculosis chemotherapy. Kekkaku, 2011,86(2):87-99.
URL pmid: 21404653 |
[5] |
Adam J, Pichler WJ, Yerly D . Delayed drug hypersensitivity: models of T-cellstimulation. Br J Clin Pharmacol, 2011,71(5):701-707.
doi: 10.1111/j.1365-2125.2010.03764.x URL pmid: 3093075 |
[6] |
Takahashi R, Kano Y, Yamazaki Y , et al. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol, 2009,182(12):8071-8079.
doi: 10.4049/jimmunol.0804002 URL pmid: 19494333 |
[7] |
Yerly D, Pompeu YA, Schutte RJ , et al.Structural Elements Recognized by Abacavir-Induced T Cells.Int J Mol Sci, 2017, 18(7). pii: E1464.
doi: 10.3390/ijms18071464 URL pmid: 28686208 |
[8] |
Sang-Heon K, Young-Koo J, Jae-Hyung L , et al. ABCC2Haplotype is Associated With Antituberculosis Drug-Induced Maculopapular Eruption. Allergy Asthma Immunol Res, 2012,4(6):362-366.
doi: 10.4168/aair.2012.4.6.362 URL pmid: 23115734 |
[9] |
Vaghela JH, Nimbark V, Barvaliya M , et al. Antituberculosis Drug-Induced Fixed Drug Eruption: A Case Report. Drug Saf Case Rep, 2018,5(1):23.
doi: 10.1007/s40800-018-0086-z URL |
[10] |
Bondalapati S, Dharma RV, Rampure D . Isoniazid Induced Cutaneous Leukocytoclastic Vasculitis in Extra Pulmonary Tuberculosis (Pott’s Spine): A Case Report. J Clin Diagn Res, 2014,8(8):3-5.
doi: 10.7860/JCDR/2014/9000.4688 URL pmid: 25302231 |
[11] |
Ladhari C, Fathallah N, Mokni S , et al. Lichenoid drug eruption associated with rifampicin. Presse Med, 2018,47(3):281-282.
doi: 10.1016/j.lpm.2018.01.007 URL |
[12] | Manchanda Y, Das S, Sarda A , et al. Controversies in the Management of Cutaneous Adverse Drug Reactions. Indian J Dermatol, 2018,63(2):125-130. |
[13] |
Lehloenya RJ, Dheda K . Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future. Expert Rev Anti Infect Ther, 2012,10(4):475-486.
doi: 10.1586/eri.12.13 URL pmid: 22512756 |
[14] |
Bigby MD . Rates of cutaneous reactions to drugs. Arch Dermatol, 2001,137(6):765-770.
doi: 10.1046/j.1468-3083.2000.00167.x URL pmid: 11405768 |
[15] |
Eremy A, Schneider, Philip R . Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Adv Ther, 2017,34(6):1235-1244.
doi: 10.1007/s12325-017-0530-y URL pmid: 28439852 |
[16] |
Paulmann M, Mockenhaupt M . Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy. J Dtsch Dermatol Ges, 2015,13(7):625-645.
doi: 10.1111/ddg.12747 URL pmid: 26110722 |
[17] |
Kano Y, Tohyama M, Aihara M , et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J Dermatol, 2015,42(3):276-282.
doi: 10.1111/1346-8138.12770 URL pmid: 25623158145 |
[18] |
Jung HY, Park S, Shin B , et al. Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study. Allergy Asthma Immunol Res, 2019,11(1):90-103.
doi: 10.4168/aair.2019.11.1.90 URL |
[19] |
Allouchery M, Logerot S, Cottin J , et al. Antituberculosis Drug-Associated DRESS: A Case Series. J Allergy Clin Immunol Pract, 2018,6(4):1373-1380.
doi: 10.1016/j.jaip.2017.11.021 URL pmid: 29274824 |
[20] |
孙晨, 王华 . 药物激发试验在药物超敏反应诊断中的应用. 国际皮肤性病学杂志, 2016,42(4):230-232.
doi: 10.3760/cma.j.issn.1673-4173.2016.04.009 URL |
[21] |
Kasumagic-Halilovic E, Ovcina-Kurtovic N . Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis. Med Arch, 2018,72(4):276-279.
doi: 10.5455/medarh. URL |
[22] |
Lee AY, Jung SY . Two patients with isoniazid-induced photosensitive lichenoid eruptions confirmed by photopatch test. Photodermatol Photoimmunol Photomed, 1998,14(2):77-78.
doi: 10.1111/j.1600-0781.1998.tb00017.x URL pmid: 9638730 |
[23] |
Shebe K, Ngwanya MR, Gantsho N , et al. Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man. Contact Dermatitis, 2014,70(2):125-127.
doi: 10.1111/cod.12155 URL pmid: 24450829 |
[24] |
Lehloenya RJ, Todd G, Wallace J , et al. Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons. Br J Dermatol, 2016,175(1):150-156.
doi: 10.1111/bjd.14492 URL pmid: 26918554 |
[25] |
雷建平 . 抗结核药物超敏反应实验室诊断方法研究进展及期望. 中国防痨杂志, 2015,37(9):923-927.
doi: 10.3969/j.issn.1000-6621.2015.05.002 URL |
[26] |
孙勤, 沙巍, 桂徐蔚 , 等. 药物淋巴细胞刺激试验对于诊断抗结核药物所致超敏反应的价值及意义. 中国防痨杂志, 2014,36(12):1062-1066.
doi: 10.3969/j.issn.1000-6621.2014.12.012 URL |
[27] |
Kobashi Y, Okimoto N, Matsushima T , et al. Desensitization therapy for allergic reactions of antituberculous drugs-evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis. Kekkaku, 2000,75(12):699-704.
URL pmid: 11201137 |
[28] |
Kobashi Y, Abe T, Shigeto E , et al. Desensitization therapy for allergic reactions to antituberculous drugs. Intern Med, 2010,49(21):2297-2301.
doi: 10.2169/internalmedicine.49.3590 URL pmid: 21048363 |
[29] |
Chihara Y, Takahashi KI, Sakai N , et al. Successful desensitization therapy for a patient with isoniazid-induced hypersensitivity pneumonia. Respir Med Case Rep, 2016,18:78-80.
doi: 10.1016/j.rmcr.2016.05.003 URL |
[30] |
Siripassorn K, Ruxrungtham K, Manosuthi W . Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs. Int J Infect Dis, 2018,68:61-68.
doi: 10.1016/j.ijid.2018.01.006 URL pmid: 29410254 |
[31] |
Collado-Chagoya R, Hernández-Romero J, Eliosa-Alvarado GA , et al. Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap. Allergy Rhinol (Providence), 2018,9:2152656718783618.
doi: 10.1177/2152656718783618 URL |
[32] |
Pech O, May A, Henrich R , et al. Oral rapid desensitization with rifampicin. Dtsch Med Wochenschr, 2001,126(1-2):16.
doi: 10.1055/s-2001-9885 URL |
[33] |
Holland CL, Malasky C, Ogunkoya A , et al. Rapid oral desensitization to isoniazid and rifampin. Chest, 1990,98(6):1518-1519.
doi: 10.1016/0091-6749(88)90448-4 URL pmid: 2245698 |
[34] |
张玉兰 . 利福平、异烟肼过敏性皮炎脱敏疗法21例报告. 中国防痨杂志, 2000,22(4):240.
doi: 10.3969/j.issn.1000-6621.2000.04.031 URL |
[35] |
Thong BY, Chia FL, Tan SC , et al. A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy. Asia Pac Allergy, 2014,4(3):156-163.
doi: 10.5415/apallergy.2014.4.3.156 URL pmid: 4116042 |
[1] | MA Hui-min, ZHANG Li-fan, LIU Xiao-qing. Research progress on the mechanism of latent tuberculosis infection progressing to active tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 276-280. |
[2] | WANG Le-le, YANG Song, TANG Shen-jie. Progress on changes of micronutrients and nutritional therapy of active pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 281-284. |
[3] | Rena·Abulaiti, Kelibiena·Tuerxun, Dilinuer·Wufuer. Research progress on correlation between bronchial asthma and psychological disorders [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 285-288. |
[4] | MA Yan, YANG Xiao-jun, REN Zhen-juan, SU Yun-kai. Clinical value of Genechip in detecting multidrug-resistant Mycobacterium tuberculosis bacteria in sputum samples [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 112-116. |
[5] | TANG Gui-hua, SUN Qian, WANG Xiao-fan, XIAN Hai-bin, ZHANG Qian, YANG Xiao-wei, WANG Li. The value of GeneXpert MTB/RIF technology in tuberculosis detection and resistance to rifampin [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 121-125. |
[6] | LIN Pei-xin, ZHANG Chen-chen. Current status and intervention progress of latent tuberculosis infection in student population [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 170-173. |
[7] | FENG Feng, TANG Feng-zhen, YAO Ming-mei, CHENG Lu, DU Li-jun. Application progress of proteome in research of the Mycobacterium tuberculosis infection [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 174-178. |
[8] | HU Xiao-guang, CHEN Can-can, ZHANG Ya-nan, MA Jun-yang, CHEN Wei. The main immune cells against Mycobacterium tuberculosis infection and their mechanisms [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 71-77. |
[9] | YAO Jing, GU Kai-kan, LI Zhi-hong, HAN Zhi-ying, ZHANG Huai-qing. Research progress on latent tuberculosis infection [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 82-88. |
[10] | Fu-ping YANG,Kun LEI,Song YANG. Research progress on glucocorticoids application in treatment of patients with tracheobronchial tuberculosis [J]. Journal of Tuberculosis and Lung Health, 2019, 8(4): 299-302. |
[11] | YU Da-wei,SONG Hua-feng,QIU Wen-na,XUE Jing,LI Fang-hua,XU Ping. Application value of GeneXpert MTB/RIF in the detection of MTB rifampicin resistance [J]. Journal of Tuberculosis and Lung Health, 2019, 8(3): 160-162. |
[12] | WU Hai-yan,YE Zhi-jian,WANG Xia-fang,YU Xin,WU Mei-ying.. Evaluation of clinical value of GeneXpert MTB/RIF in diagnosis and drug resistance detection of pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Health, 2019, 8(3): 172-177. |
[13] | Yong-ming LIN,Xiao-wei HUANG,Shu-fang LIN,Shu-zhen WEI,Jian LIN,Yong ZHAO. Analysis of detection of rifampicin-resistant tuberculosis and rpoB gene mutation by using different methods [J]. Journal of Tuberculosis and Lung Health, 2019, 8(2): 121-126. |
[14] | Yin-fa ZHOU,Yan-pin LI,Shu-zhen WEI,Shu-fang LIN,Yong ZHAO,Jian-li ZHEN,Jian LIN,Shan-ying ZHANG. The value of GeneXpert MTB/RIF in diagnosis of pulmonary tuberculosis with smear-negative and rifampicin resistance [J]. Journal of Tuberculosis and Lung Health, 2019, 8(2): 133-137. |
[15] | Jing YAO,Xin SHEN,Kai-kan GU,Zhi-hong LI,Zhi-ying HAN,Huai-qing ZHANG,Bing SHEN. The global and national tuberculosis epidemic situation of children and schools [J]. Journal of Tuberculosis and Lung Health, 2019, 8(2): 142-145. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||